Hemin as a potential therapy for COVID-19 – News-Medical.Net

Presently, there is no licensed antiviral drug in the market that specifically treats the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Considering the devastating effects caused by the coronavirus disease‐19 (COVID-19) pandemic,…

Click here to view the original article.